SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005018
Filing Date
2014-11-05
Accepted
2014-11-05 16:05:54
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20140930.htm 10-Q 1712602
2 EX-31.1 dvax-ex311_201409309.htm EX-31.1 17370
3 EX-31.2 dvax-ex312_201409308.htm EX-31.2 17399
4 EX-32.1 dvax-ex321_201409306.htm EX-32.1 9186
5 EX-32.2 dvax-ex322_201409307.htm EX-32.2 9166
  Complete submission text file 0001564590-14-005018.txt   7606743

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20140930.xml EX-101.INS 1275119
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20140930.xsd EX-101.SCH 31465
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20140930_cal.xml EX-101.CAL 43797
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20140930_def.xml EX-101.DEF 137938
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20140930_lab.xml EX-101.LAB 301186
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20140930_pre.xml EX-101.PRE 227930
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 141196959
SIC: 2834 Pharmaceutical Preparations